Abbott Gets FDA Approval for Dual-Chamber Leadless Pacemaker

July 5, 2023, 1:04 PM UTC

Abbott received FDA approval for the AVEIR dual chamber leadless pacemaker system.

  • Approval for first dual chamber leadless pacing system that treats people with abnormal or slow heart rhythms: statement

To view the source of this information, click here

To contact the reporter on this story:
Georgi Azar in New York at gazar4@bloomberg.net

To contact the editor responsible for this story:
Sunil Kesur at skesur@bloomberg.net

© 2023 Bloomberg L.P. All rights reserved. Used with permission.

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.